Stuka Paul 4
4 · InspireMD, Inc. · Filed May 12, 2026
Research Summary
AI-generated summary of this filing
InspireMD (NSPR) Director Paul Stuka Buys 75,626 Shares
What Happened
- Paul Stuka, a director of InspireMD (NSPR), made open-market purchases totaling 75,626 shares of common stock: 65,626 shares on May 8 at a weighted average price of $1.16 (≈ $76,126) and 10,000 shares on May 11 at a weighted average price of $1.19 (≈ $11,900). Total consideration for the purchases was about $88,026. These were purchases (insider buys), which investors often view as a more informative signal than routine sales.
Key Details
- Transaction dates & prices:
- 2026-05-08 — 65,626 shares at a weighted avg price reported as $1.16 (individual trades ranged $1.15–$1.16). (Footnote F1)
- 2026-05-11 — 10,000 shares at a weighted avg price reported as $1.19 (individual trades ranged $1.17–$1.20). (Footnote F4)
- Shares owned after the transactions (as reported):
- Directly beneficially owned: approx. 632,871 shares (557,245 before these purchases + 75,626 purchased).
- Indirectly beneficially owned through Osiris Investment Partners, L.P.: 423,704 shares (no change reported). (Footnotes F2, F3)
- Other notable footnotes:
- F2–F5 explain corrections to prior filings and clarify certain shares are held by Osiris; Stuka serves as managing member of Osiris Partners, LLC and disclaims beneficial ownership except to the extent of his pecuniary interest.
- No 10b5-1 plan, option exercise, gift, or tax-withholding event was reported — these were straight open-market purchases (code P).
- Filing timeliness: The Form 4 was filed May 12, 2026 and covers purchases on May 8 and May 11; this filing is within the SEC’s two-business-day window and is therefore timely.
Context
- These were direct open-market purchases (not option exercises or awards). Purchases by directors can reflect confidence in the company, but they are one data point among many — avoid assuming motive. The footnotes clarify prior reporting corrections and the distinction between shares held directly vs. indirectly through an entity Stuka manages.
Insider Transaction Report
Form 4
InspireMD, Inc.NSPR
Stuka Paul
Director
Transactions
- Purchase
Common Stock
[F1][F2][F3]2026-05-08$1.16/sh+65,626$76,126→ 622,871 total - Purchase
Common Stock
[F4]2026-05-11$1.19/sh+10,000$11,900→ 632,871 total
Holdings
- 423,704(indirect: See Footnote)
Common Stock
[F2][F3][F5]
Footnotes (5)
- [F1]The price reported is a weighted average price. The reported securities were purchased in multiple transactions at prices ranging from $1.15 to $1.16. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
- [F2]The Form 4 filed on August 1, 2025 (the "Original Filing") (and subsequent Form 4s reflecting this information) inadvertently reported that 20,661 shares of common stock purchased on July 30, 2025 were indirectly held by the Reporting Person through Osiris Investment Partners, L.P. ("Osiris"). However, such shares were held directly by the Reporting Person. After adjusting for the foregoing and further technical adjustments, the Reporting Person (i) directly beneficially owned 557,245 shares of Common Stock and (ii) indirectly, through Osiris, beneficially owned 423,704 shares of Common Stock, in each case immediately prior to the transaction reported herein.
- [F3]This Form 4 reflects the Reporting Person's correct beneficial ownership following the transaction reported herein. No change in the Reporting Person's pecuniary interest resulted from these corrections.
- [F4]The price reported is a weighted average price. The reported securities were purchased in multiple transactions at prices ranging from $1.17 to $1.20. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
- [F5]These securities are held by Osiris. The Reporting Person serves as the managing member of Osiris Partners, LLC, the general partner of Osiris. In such capacity, the Reporting Person may be deemed to beneficially own the reported securities. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein, and the inclusion of such securities in this report shall not be deemed an admission of beneficial ownership for purposes of Section 16 or for any other purposes. No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only.
Signature
/s/ Michael Lawless, Attorney-in-Fact for Paul Stuka|2026-05-12